Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Big bottlenecks in cardiovascular tissue engineering.

Huang NF, Serpooshan V, Morris VB, Sayed N, Pardon G, Abilez OJ, Nakayama KH, Pruitt BL, Wu SM, Yoon YS, Zhang J, Wu JC.

Commun Biol. 2018 Nov 21;1:199. doi: 10.1038/s42003-018-0202-8. eCollection 2018.

2.

Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Park M, Yoon YS.

Korean Circ J. 2018 Nov;48(11):974-988. doi: 10.4070/kcj.2018.0312. Review.

3.

Generation of Human Pluripotent Stem Cell-derived Endothelial Cells and Their Therapeutic Utility.

Lee SJ, Kim KH, Yoon YS.

Curr Cardiol Rep. 2018 May 5;20(6):45. doi: 10.1007/s11886-018-0985-8. Review.

4.

Design of Polymeric Culture Substrates to Promote Proangiogenic Potential of Stem Cells.

Kwon BJ, Wang X, Kang ML, You J, Lee SJ, Kim WS, Yoon YS, Park JC, Sung HJ.

Macromol Biosci. 2018 Feb;18(2). doi: 10.1002/mabi.201700340. Epub 2017 Dec 29. Review.

PMID:
29285899
5.

Enhanced Therapeutic and Long-Term Dynamic Vascularization Effects of Human Pluripotent Stem Cell-Derived Endothelial Cells Encapsulated in a Nanomatrix Gel.

Lee SJ, Sohn YD, Andukuri A, Kim S, Byun J, Han JW, Park IH, Jun HW, Yoon YS.

Circulation. 2017 Nov 14;136(20):1939-1954. doi: 10.1161/CIRCULATIONAHA.116.026329. Epub 2017 Sep 29.

6.

Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering.

Yanamandala M, Zhu W, Garry DJ, Kamp TJ, Hare JM, Jun HW, Yoon YS, Bursac N, Prabhu SD, Dorn GW 2nd, Bolli R, Kitsis RN, Zhang J.

J Am Coll Cardiol. 2017 Aug 8;70(6):766-775. doi: 10.1016/j.jacc.2017.06.012. Review.

7.

Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells.

Ban K, Bae S, Yoon YS.

Theranostics. 2017 May 17;7(7):2067-2077. doi: 10.7150/thno.19427. eCollection 2017. Review.

8.

Direct reprogramming into endothelial cells: a new source for vascular regeneration.

Lee S, Kim JE, Johnson BA, Andukuri A, Yoon YS.

Regen Med. 2017 Apr;12(4):317-320. doi: 10.2217/rme-2017-0022. Epub 2017 Jun 16. Review. No abstract available.

9.

Modified Mouse Models of Chronic Secondary Lymphedema: Tail and Hind Limb Models.

Jun H, Lee JY, Kim JH, Noh M, Kwon TW, Cho YP, Yoon YS.

Ann Vasc Surg. 2017 Aug;43:288-295. doi: 10.1016/j.avsg.2017.01.023. Epub 2017 May 4.

PMID:
28479437
10.

Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2.

Lee S, Park C, Han JW, Kim JY, Cho K, Kim EJ, Kim S, Lee SJ, Oh SY, Tanaka Y, Park IH, An HJ, Shin CM, Sharma S, Yoon YS.

Circ Res. 2017 Mar 3;120(5):848-861. doi: 10.1161/CIRCRESAHA.116.309833. Epub 2016 Dec 21.

11.

Novel Multifunctional Nanomatrix Reduces Inflammation in Dynamic Conditions in Vitro and Dilates Arteries ex Vivo.

Alexander GC, Vines JB, Hwang P, Kim T, Kim JA, Brott BC, Yoon YS, Jun HW.

ACS Appl Mater Interfaces. 2016 Mar 2;8(8):5178-87. doi: 10.1021/acsami.6b00565. Epub 2016 Feb 17.

12.

Non-genetic Purification of Ventricular Cardiomyocytes from Differentiating Embryonic Stem Cells through Molecular Beacons Targeting IRX-4.

Ban K, Wile B, Cho KW, Kim S, Song MK, Kim SY, Singer J, Syed A, Yu SP, Wagner M, Bao G, Yoon YS.

Stem Cell Reports. 2015 Dec 8;5(6):1239-1249. doi: 10.1016/j.stemcr.2015.10.021.

13.

Therapeutic effects of late outgrowth endothelial progenitor cells or mesenchymal stem cells derived from human umbilical cord blood on infarct repair.

Kim SW, Jin HL, Kang SM, Kim S, Yoo KJ, Jang Y, Kim HO, Yoon YS.

Int J Cardiol. 2016 Jan 15;203:498-507. doi: 10.1016/j.ijcard.2015.10.110. Epub 2015 Oct 23.

14.

Enhanced therapeutic neovascularization by CD31-expressing cells and embryonic stem cell-derived endothelial cells engineered with chitosan hydrogel containing VEGF-releasing microtubes.

Lee S, Valmikinathan CM, Byun J, Kim S, Lee G, Mokarram N, Pai SB, Um E, Bellamkonda RV, Yoon YS.

Biomaterials. 2015 Sep;63:158-67. doi: 10.1016/j.biomaterials.2015.06.009. Epub 2015 Jun 11.

15.

Generation of pure lymphatic endothelial cells from human pluripotent stem cells and their therapeutic effects on wound repair.

Lee SJ, Park C, Lee JY, Kim S, Kwon PJ, Kim W, Jeon YH, Lee E, Yoon YS.

Sci Rep. 2015 Jun 12;5:11019. doi: 10.1038/srep11019.

16.

Bone Marrow-Derived Mesenchymal Stem Cells Improve Diabetic Neuropathy by Direct Modulation of Both Angiogenesis and Myelination in Peripheral Nerves.

Han JW, Choi D, Lee MY, Huh YH, Yoon YS.

Cell Transplant. 2016;25(2):313-26. doi: 10.3727/096368915X688209. Epub 2015 May 13.

17.

Cultured human bone marrow-derived CD31(+) cells are effective for cardiac and vascular repair through enhanced angiogenic, adhesion, and anti-inflammatory effects.

Kim SW, Houge M, Brown M, Davis ME, Yoon YS.

J Am Coll Cardiol. 2014 Oct 21;64(16):1681-94. doi: 10.1016/j.jacc.2014.06.1204.

18.

Molecular beacon-enabled purification of living cells by targeting cell type-specific mRNAs.

Wile BM, Ban K, Yoon YS, Bao G.

Nat Protoc. 2014 Oct;9(10):2411-24. doi: 10.1038/nprot.2014.154. Epub 2014 Sep 18.

19.

Cell therapy with embryonic stem cell-derived cardiomyocytes encapsulated in injectable nanomatrix gel enhances cell engraftment and promotes cardiac repair.

Ban K, Park HJ, Kim S, Andukuri A, Cho KW, Hwang JW, Cha HJ, Kim SY, Kim WS, Jun HW, Yoon YS.

ACS Nano. 2014 Oct 28;8(10):10815-25. doi: 10.1021/nn504617g. Epub 2014 Sep 15.

20.

Evaluation of the effect of expansion and shear stress on a self-assembled endothelium mimicking nanomatrix coating for drug eluting stents in vitro and in vivo.

Andukuri A, Min I, Hwang P, Alexander G, Marshall LE, Berry JL, Wick TM, Joung YK, Yoon YS, Brott BC, Han DK, Jun HW.

Biofabrication. 2014 Sep;6(3):035019. doi: 10.1088/1758-5082/6/3/035019. Epub 2014 Jul 22.

Supplemental Content

Loading ...
Support Center